Provider and Caregiver Connection™️: Addressing Patient Concerns During the Treatment of cSCC With Immunotherapy

Provider and Caregiver Connection™?: Addressing Patient Concerns During the Treatment of cutaneous squamous cell carcinoma (cSCC) With Immunotherapy is organized by Physicians' Education Resource, LLC (PER).

Release Date: November 27, 2019
Expiration Date: November 27, 2020

Accreditation:
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 2.0 Contact Hours.

Activity Overview:
As new agents are available for the treatment of advanced and metastatic cutaneous squamous cell carcinoma (cSCC), there is a need to educate practitioners on the incorporation of recently approved agents into practice based on clinical data. Management of these patients is multidisciplinary and, therefore, possible application of immunotherapeutic approaches must be part of the discussion amongst multidisciplinary colleagues to optimally plan multimodal treatment regimens.

Practitioners who manage cSCC must be knowledgeable in recent strategies for treatment of cSCC, including immunotherapy. Practitioners must also be aware of new treatment-related toxicities associated with immunotherapy and take measures for clear communication with the patient and the caregiver(s) about treatment goals and preemptive management of possible adverse events.

To help you meet this challenge, this Provider and Caregiver Connection™ presents a series of audio interviews with Omid Hamid, MD, an expert in cSCC, who will discuss the current standards of care for advanced and metastatic disease, the recent integration of immunotherapy into the treatment paradigm for cSCC, and the multidisciplinary approach to treatment of cSCC. In addition, Nikhil Khushalani, MD, an expert in cutaneous malignancies, discusses the patient and caregiver experience with George Ebanks, BSN, RN,OCN, an experienced oncology nurse; his patient and survivor of locally advanced cSCC, Tim Nugent; and Tim’s wife and caregiver, Cathy Rowe. This discussion provides insight into the patient and caregiver journey from initial diagnosis through treatment that involved immunotherapy.

Learning Objectives:
Upon successful completion of this educational activity, you should be better prepared to:
• Discuss unmet needs related to treatment of advanced/metastatic cSCC and review emerging treatment paradigms.
• Review recent evidence regarding the use of immunotherapeutic strategies and its impact in the context of changing cSCC care paradigms.
• Utilize multidisciplinary approaches to plan for and proactively mitigate the impact of immune related adverse events (irAEs) in patients with advanced/metastatic cSCC.
• Identify and address patient concerns in the treatment of advanced/metastatic cSCC.